Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3
- PMID: 21536977
- DOI: 10.1001/archgenpsychiatry.2011.43
Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3
Abstract
Context: The hippocampus is strongly implicated in schizophrenia and, to a lesser degree, bipolar disorder. Proteomic investigations of the different regions of the hippocampus may help us to clarify the basis and the disease specificity of the changes.
Objective: To determine whether schizophrenia and bipolar disorder are associated with distinct patterns of differential protein expression in specific regions of the hippocampus.
Design, setting, and patients: A postmortem comparative proteomic study, including validation of differential expression, was performed. Midhippocampus samples from well-matched groups of 20 subjects with schizophrenia, 20 subjects with bipolar disorder, and 20 control cases from the Stanley Medical Research Institute Array Collection were analyzed.
Main outcome measures: We used laser-assisted microdissection to enrich for tissue from the hippocampal regions and 2-dimensional difference gel electrophoresis to compare protein profiles. Levels of differentially expressed proteins were confirmed by enzyme-linked immunosorbent assay and Western blotting. Hippocampi from haloperidol-treated mice were used to help discriminate drug-associated from disease-associated protein changes.
Results: Across all hippocampal regions, 108 protein spots in schizophrenia and 165 protein spots in bipolar disorder were differentially expressed compared with controls. Sixty-one proteins were differentially expressed in both disorders. One hundred fifty-two of these proteins were identified by mass spectrometry, and they implicated a range of different processes including cytoskeletal and metabolic functions. In both disorders, cornu ammonis regions 2 and 3 were affected to a significantly greater degree than other hippocampal regions. Additionally, numerous proteins showed expression changes in more than 1 region and more than 1 disorder. Validation work confirmed changes in septin 11 and in the expression of proteins involved in clathrin-mediated endocytosis in both schizophrenia and bipolar disorder.
Conclusions: Overall, similar protein changes were observed in schizophrenia and bipolar disorder and for the first time indicate that the most prominent proteomic changes occur within the hippocampus in cornu ammonis regions 2 and 3. The cytoskeletal protein septin 11 and the cellular trafficking process of clathrin-mediated endocytosis are implicated by our study.
Similar articles
-
Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology.Schizophr Res. 2015 Sep;167(1-3):64-72. doi: 10.1016/j.schres.2015.02.002. Epub 2015 Feb 23. Schizophr Res. 2015. PMID: 25728835
-
Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.JAMA Psychiatry. 2015 Jun;72(6):541-51. doi: 10.1001/jamapsychiatry.2015.49. JAMA Psychiatry. 2015. PMID: 25738424 Free PMC article.
-
Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.Mol Psychiatry. 2008 Dec;13(12):1102-17. doi: 10.1038/sj.mp.4002098. Epub 2007 Oct 16. Mol Psychiatry. 2008. PMID: 17938637
-
Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?Mol Psychiatry. 2012 Jul;17(7):669-81. doi: 10.1038/mp.2011.123. Epub 2011 Oct 11. Mol Psychiatry. 2012. PMID: 21986877 Review.
-
Neuroimaging hippocampal subfields in schizophrenia and bipolar disorder: A systematic review and meta-analysis.J Psychiatr Res. 2018 Sep;104:217-226. doi: 10.1016/j.jpsychires.2018.08.012. Epub 2018 Aug 7. J Psychiatr Res. 2018. PMID: 30107268 Review.
Cited by
-
Proteomics Research in Schizophrenia.Front Cell Neurosci. 2016 Feb 16;10:18. doi: 10.3389/fncel.2016.00018. eCollection 2016. Front Cell Neurosci. 2016. PMID: 26909022 Free PMC article. Review.
-
The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia.Schizophr Res. 2020 Mar;217:148-161. doi: 10.1016/j.schres.2019.07.025. Epub 2019 Aug 13. Schizophr Res. 2020. PMID: 31416743 Free PMC article.
-
Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients.J Pers Med. 2021 Feb 25;11(3):160. doi: 10.3390/jpm11030160. J Pers Med. 2021. PMID: 33668817 Free PMC article.
-
Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1.J Neurosci. 2012 Mar 14;32(11):3697-711. doi: 10.1523/JNEUROSCI.5640-11.2012. J Neurosci. 2012. PMID: 22423091 Free PMC article.
-
MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia.Front Cell Neurosci. 2015 May 12;9:180. doi: 10.3389/fncel.2015.00180. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26029051 Free PMC article.